CEBPA Gene mutation in AML by direct sequencing

18,000 THB

SKU :

MD-NLMM932

Detects mutations in the CEBPA gene, important for prognosis in acute myeloid leukemia (AML).

Diseases :

Symptoms : ,

Habits :

Age Groups :

Specimens : ,

Diagnostic Methods :

Detects mutations in the CEBPA gene, important for prognosis in acute myeloid leukemia (AML)…. This lab test includes home sample collection via a provided kit or by a clinician, and you’ll receive a comprehensive physical health report with your results.

Also Known As

CEBPA Mutation Test

Specimen

EDTA Whole Blood 1 – 3 ml OR EDTA Bone marrow 1 – 3 ml.

Turnaround Time

21 Days

Test Code

MD-NLMM932

Test Type

Special

Related Product

Shopping Cart
Scroll to Top